MEET THE TEAM : VUmc AMSTERDAM
–
STICHTING-VUmc
Department of Radiology & Nuclear Medicine
The Netherlands
Professor Albert D. Windhorst
Chair of Radiopharmaceutical Chemistry
Expert in the development of radiopharmaceuticals in drug development. He leads a group of 43 persons (staff, post-doc, PhD, technicians) and is a teacher of radiopharmaceutical sciences at the VUmc University Amsterdam. President of the Society for Radiopharmaceutical sciences, editor of the Journal of Radiolabelled Compounds & Radiopharmaceuticals, and member of the editorial board of several journals. Co-author of more than 100 articles and book-chapters, and co-inventor on 13 patent applications.
Dr. Daniëlle J. Vugts
PhD, 2006
An expert in pre-targeted imaging, preclinical and clinical immuno-PET imaging and development of 18F radiochemistry methods. She supervised several MSc students and is currently supervising 2 PhD students. She is lecturing on radiochemistry and radiation safety at the VUmc.
Professor Guus van Dongen
Chair of Preclinical Imaging at VUmc
Professor Albert D. Windhorst
Chair of Radiopharmaceutical Chemistry
Expert in the development of radiopharmaceuticals in drug development. He leads a group of 43 persons (staff, post-doc, PhD, technicians) and is a teacher of radiopharmaceutical sciences at the VU University Amsterdam. President of the Society for Radiopharmaceutical sciences, editor of the Journal of Radiolabelled Compounds & Radiopharmaceuticals, and member of the editorial board of several journals. Co-author of more than 100 articles and book-chapters, and co-inventor on 13 patent applications.
Dr. Daniëlle J. Vugts
PhD, 2006
An expert in pre-targeted imaging, preclinical and clinical immuno-PET imaging and development of 18F radiochemistry methods. She supervised several MSc students and is currently supervising 2 PhD students. She is lecturing on radiochemistry and radiation safety at the VU/VUmc.
Professor Guus van Dongen
Chair of Preclinical Imaging at VUmc
Research focused on the use of targeted drugs like monoclonal antibodies (mAbs) and tyrosine kinase inhibitors (TKIs) for disease detection and therapy. He introduced “immuno-PET” and “TKI-PET”, the PET imaging of radiolabeled mAbs and TKIs, respectively, as well as photo-immunodetection. He is project leader for building the world leading VUmc Imaging Center Amsterdam, comprising Tracer Center Amsterdam, and fully focused on image in drug development within public-private partnerships. He supervised 15 PhD projects, coordinates/participates in several teaching programs in the field of imaging and oncology, is author of more than 170 papers in peer-reviewed journals, participated in many EU consortia, and is inventor in several patents.